Adimmune
A Taiwan-based vaccine and biologics manufacturer offering end-to-end development and contract development and manufacturing (CDMO) services. Core operations include cell culture and egg-based vaccine production, aseptic fill-finish (vial and prefilled syringe), analytical and quality systems, regulatory support for global market entry, and environmental and occupational health management. The company holds multiple international GMP certifications and collaborates with academic and industry partners.
Industries
Nr. of Employees
large (251-1000)
Products
Seasonal and pandemic influenza vaccines
Production and supply of trivalent and quadrivalent seasonal influenza vaccines and pandemic influenza vaccine readiness under pandemic preparedness agreements.
Tetanus toxoid and other routine vaccines
Manufacture of tetanus toxoid vaccine and other routine immunizations such as Japanese encephalitis and enterovirus vaccines.
Seasonal and pandemic influenza vaccines
Production and supply of trivalent and quadrivalent seasonal influenza vaccines and pandemic influenza vaccine readiness under pandemic preparedness agreements.
Tetanus toxoid and other routine vaccines
Manufacture of tetanus toxoid vaccine and other routine immunizations such as Japanese encephalitis and enterovirus vaccines.
Services
Contract Development and Manufacturing (CDMO)
End-to-end CDMO services including process development, scale-up, GMP manufacturing, fill–finish, quality control, and regulatory support.
Analytical and Quality Testing Services
Analytical method development, method validation support, qualification testing, sterility testing, and stability programs for biologics.
Regulatory and CMC Dossier Support
Regulatory operations, CMC development, quality and compliance documentation, and dialogue with global regulatory authorities to support marketing authorization.
Process Development and Scale-Up
Process optimization, scale-up assistance from laboratory to commercial bioreactors, and implementation of QbD principles.
Contract Development and Manufacturing (CDMO)
End-to-end CDMO services including process development, scale-up, GMP manufacturing, fill–finish, quality control, and regulatory support.
Analytical and Quality Testing Services
Analytical method development, method validation support, qualification testing, sterility testing, and stability programs for biologics.
Regulatory and CMC Dossier Support
Regulatory operations, CMC development, quality and compliance documentation, and dialogue with global regulatory authorities to support marketing authorization.
Process Development and Scale-Up
Process optimization, scale-up assistance from laboratory to commercial bioreactors, and implementation of QbD principles.
Expertise Areas
- CDMO services for vaccines and biologics
- Vaccine R&D and clinical trial support
- Cell culture and egg-based vaccine manufacturing
- Aseptic fill–finish and packaging
Key Technologies
- Cell culture production
- Embryo egg-based production
- Single-use bioreactors
- Aseptic isolator operations